SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-21-004117
Filing Date
2021-04-09
Accepted
2021-04-09 16:05:59
Documents
4
Period of Report
2021-05-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20210521xdef14a.htm DEF 14A 993929
2 GRAPHIC tmb-20210521xdef14a012.jpg GRAPHIC 92770
3 GRAPHIC tmb-20210521xdef14a011.jpg GRAPHIC 110985
4 GRAPHIC tmb-20210521xdef14a001.jpg GRAPHIC 4672
  Complete submission text file 0001558370-21-004117.txt   1282549
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36721 | Film No.: 21817873
SIC: 2836 Biological Products, (No Diagnostic Substances)